UnitedHealth Group Inc. Stock

Equities

UNH

US91324P1021

Managed Healthcare

Market Closed - Nyse 04:00:01 2024-04-24 pm EDT 5-day change 1st Jan Change
487.3 USD +0.23% Intraday chart for UnitedHealth Group Inc. +1.73% -7.44%
Sales 2024 * 399B Sales 2025 * 430B Capitalization 448B
Net income 2024 * 16.71B Net income 2025 * 27.04B EV / Sales 2024 * 1.18 x
Net Debt 2024 * 24.01B Net Debt 2025 * 14.47B EV / Sales 2025 * 1.08 x
P/E ratio 2024 *
26.9 x
P/E ratio 2025 *
16.4 x
Employees 440,000
Yield 2024 *
1.61%
Yield 2025 *
1.79%
Free-Float 99.98%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.23%
1 week+1.73%
Current month-1.50%
1 month-0.57%
3 months-5.05%
6 months-7.18%
Current year-7.44%
More quotes
1 week
480.71
Extreme 480.71
507.30
1 month
436.38
Extreme 436.38
507.30
Current year
436.38
Extreme 436.38
549.00
1 year
436.38
Extreme 436.38
554.70
3 years
383.12
Extreme 383.12
558.10
5 years
187.72
Extreme 187.72
558.10
10 years
74.26
Extreme 74.26
558.10
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 17-08-06
Director of Finance/CFO - 06-10-31
Director of Finance/CFO 61 16-06-06
Members of the board TitleAgeSince
Director/Board Member 67 17-01-12
Director/Board Member 72 06-12-31
Chairman 71 97-05-31
More insiders
Date Price Change Volume
24-04-24 487.3 +0.23% 3,724,418
24-04-23 486.2 -1.03% 3,646,662
24-04-22 491.2 -1.98% 4,697,677
24-04-19 501.1 +1.61% 6,618,600
24-04-18 493.2 +2.96% 8,880,448

Delayed Quote Nyse, April 24, 2024 at 04:00 pm EDT

More quotes
UnitedHealth Group Inc. is one of the leading American suppliers of healthcare products and services. Income breaks down by activity as follows: - health insurance (57.4%; UnitedHealthcare); - prescription insurance plan management services (39.3%; Optum Health and Optum Rx): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - provision of computer services (3.3%; Optum Insight): consulting, development, and integration of solutions for transaction management, healthcare plan management, data processing, etc.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
487.3 USD
Average target price
567.4 USD
Spread / Average Target
+16.43%
Consensus